Oncogenic-Drivers Dictate Immune Responses to Control Disease Progression in Acute Myeloid Leukaemia

MLA

Austin, Rebecca, et al. “Oncogenic-Drivers Dictate Immune Responses to Control Disease Progression in Acute Myeloid Leukaemia.” Blood, vol. 132, no. 1, Number 1 Supplement 1, Nov. 2018, p. 904. EBSCOhost, https://doi.org/10.1182/blood-2018-99-112009.

APA

Austin, R., Bywater, M., Straube, J., Cooper, L. T., Headlam, M., Dave, K., Braun, M., Bald, T., Guimaraes, F., Jacquelin, S., Witkowski, M., Aifantis, I., Hill, G. R., Smyth, M. J., & Lane, S. W. (2018). Oncogenic-Drivers Dictate Immune Responses to Control Disease Progression in Acute Myeloid Leukaemia. Blood, 132(1, Number 1 Supplement 1), 904. https://doi.org/10.1182/blood-2018-99-112009

Chicago

Austin, Rebecca, Megan Bywater, Jasmin Straube, Leanne T Cooper, Madeleine Headlam, Keyur Dave, Matthias Braun, et al. 2018. “Oncogenic-Drivers Dictate Immune Responses to Control Disease Progression in Acute Myeloid Leukaemia.” Blood 132 (1, Number 1 Supplement 1): 904. doi:10.1182/blood-2018-99-112009.